Initial Statement of Beneficial Ownership (3)
08 Marzo 2018 - 4:28PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
ROESCHLEIN BILL
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
4/3/2017
|
3. Issuer Name
and
Ticker or Trading Symbol
INTERMOLECULAR INC [IMI]
|
(Last)
(First)
(Middle)
C/O INTERMOLECULAR, INC., 3011 NORTH FIRST STREET
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
_____ 10% Owner
___
X
___ Officer (give title below)
_____ Other (specify below)
Chief Financial Officer /
|
(Street)
SAN JOSE, CA 95134
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
No securities beneficially owned as of April 3, 2017
|
0
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Stock Option (right to buy)
|
(1)
|
8/30/2025
|
Common Stock
|
100000
|
$2.04
|
D
|
|
Stock Option (right to buy)
|
(2)
|
9/20/2026
|
Common Stock
|
54000
|
$0.99
|
D
|
|
Explanation of Responses:
|
(1)
|
Twenty-five percent (25%) of the shares shall vest and become exercisable on August 10, 2016 and 1/48th of the shares shall vest and become exercisable on each monthly anniversary thereafter.
|
(2)
|
The option grant vests monthly over 4 years from the date of grant.
|
Remarks:
This Form 3 is filed late.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
ROESCHLEIN BILL
C/O INTERMOLECULAR, INC.
3011 NORTH FIRST STREET
SAN JOSE, CA 95134
|
|
|
Chief Financial Officer
|
|
Signatures
|
/s/ Bill Roeschlein
|
|
3/8/2018
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Intermolecular (NASDAQ:IMI)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Intermolecular (NASDAQ:IMI)
Gráfica de Acción Histórica
De May 2023 a May 2024
Real-Time news about Intermolecular Inc (NASDAQ): 0 recent articles
Más de Intermolecular Inc Artículos de Noticias